Squarepoint’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$608K Sell
18,398
-85,480
-82% -$2.82M ﹤0.01% 1802
2025
Q1
$4.17M Buy
103,878
+84,039
+424% +$3.38M 0.01% 830
2024
Q4
$933K Sell
19,839
-85,968
-81% -$4.04M ﹤0.01% 1574
2024
Q3
$5.59M Buy
+105,807
New +$5.59M 0.01% 705
2024
Q2
Sell
-25,700
Closed -$1.8M 2580
2024
Q1
$1.8M Buy
+25,700
New +$1.8M ﹤0.01% 1084
2023
Q1
Sell
-16,398
Closed -$751K 2364
2022
Q4
$751K Buy
+16,398
New +$751K ﹤0.01% 1254
2022
Q2
Sell
-114,537
Closed -$4.22M 2215
2022
Q1
$4.22M Buy
114,537
+94,766
+479% +$3.49M 0.02% 543
2021
Q4
$901K Sell
19,771
-71,644
-78% -$3.26M ﹤0.01% 1274
2021
Q3
$3.27M Sell
91,415
-76,333
-46% -$2.73M 0.01% 617
2021
Q2
$3.32M Buy
167,748
+145,974
+670% +$2.89M 0.01% 601
2021
Q1
$506K Sell
21,774
-53,470
-71% -$1.24M ﹤0.01% 1516
2020
Q4
$1.56M Buy
75,244
+17,496
+30% +$364K 0.01% 851
2020
Q3
$1.25M Buy
57,748
+36,860
+176% +$798K 0.02% 833
2020
Q2
$492K Buy
+20,888
New +$492K 0.01% 1314
2020
Q1
Sell
-54,732
Closed -$581K 1974
2019
Q4
$581K Sell
54,732
-62,799
-53% -$667K ﹤0.01% 1636
2019
Q3
$1.34M Buy
117,531
+58,327
+99% +$664K 0.01% 1008
2019
Q2
$666K Buy
59,204
+29,135
+97% +$328K 0.01% 1475
2019
Q1
$243K Buy
30,069
+18,469
+159% +$149K ﹤0.01% 1816
2018
Q4
$73K Buy
11,600
+1,438
+14% +$9.05K ﹤0.01% 1812
2018
Q3
$100K Buy
+10,162
New +$100K ﹤0.01% 1878
2018
Q1
Sell
-139,925
Closed -$1.14M 1763
2017
Q4
$1.14M Buy
139,925
+68,754
+97% +$560K 0.02% 763
2017
Q3
$1.03M Sell
71,171
-9,801
-12% -$142K 0.02% 698
2017
Q2
$980K Buy
80,972
+66,312
+452% +$803K 0.02% 727
2017
Q1
$188K Buy
14,660
+4,390
+43% +$56.3K 0.01% 1292
2016
Q4
$125K Buy
+10,270
New +$125K 0.01% 1585
2016
Q2
Sell
-13,200
Closed -$93K 1148
2016
Q1
$93K Buy
+13,200
New +$93K 0.01% 1075